MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
18.49
+0.15 (0.82%)
At close: Dec 5, 2025, 4:00 PM EST
18.62
+0.13 (0.70%)
After-hours: Dec 5, 2025, 7:42 PM EST
MapLight Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -102.83 | -77.58 | -55.71 | -30.02 |
| Depreciation & Amortization | 0.63 | 0.7 | 0.56 | 0.57 |
| Loss (Gain) From Sale of Assets | 0.07 | 0.06 | - | - |
| Loss (Gain) From Sale of Investments | -1.07 | -1.74 | 0.51 | -0.8 |
| Loss (Gain) on Equity Investments | - | 0.99 | -0.99 | - |
| Stock-Based Compensation | 0.7 | 1.08 | 1.05 | 1.36 |
| Other Operating Activities | 1.35 | 0.75 | 0.53 | 0.57 |
| Change in Accounts Payable | 0.33 | -1.35 | -0.41 | 1.33 |
| Change in Unearned Revenue | -2.03 | -0.96 | -1.66 | 1.86 |
| Change in Other Net Operating Assets | -9.94 | -0.76 | 4.11 | -1.46 |
| Operating Cash Flow | -112.8 | -78.82 | -52.01 | -26.58 |
| Capital Expenditures | -0.2 | -0.77 | -0.46 | -0.75 |
| Investment in Securities | -48.06 | -80.02 | - | - |
| Investing Cash Flow | -48.26 | -80.79 | -0.46 | -0.75 |
| Issuance of Common Stock | 0.13 | 0.29 | 0.04 | 0.01 |
| Other Financing Activities | -1.14 | -2.19 | - | -0.02 |
| Financing Cash Flow | 197.86 | 118.06 | 104.57 | 33.18 |
| Net Cash Flow | 36.8 | -41.54 | 52.1 | 5.85 |
| Free Cash Flow | -113 | -79.59 | -52.47 | -27.32 |
| Free Cash Flow Per Share | -146.95 | -108.10 | -79.54 | -49.05 |
| Levered Free Cash Flow | - | -51.86 | -32.18 | - |
| Unlevered Free Cash Flow | - | -51.86 | -32.18 | - |
| Change in Working Capital | -11.64 | -3.07 | 2.04 | 1.72 |
Source: S&P Capital IQ. Standard template.
Financial Sources.